Jakafi 25 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FDM05
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,259
Award facts
- Contract value 100% obligated
- $24,258.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On September 19, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $24,258.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, with an ultimate completion date of September 22, 2025, covers the supply of Jakafi 25 mg tablets in quantities of 60, a prescription medication used in the treatment of myelofibrosis and polycythemia vera. This delivery order was issued without a set-aside designation, leveraging the company's competitive status as a woman-owned small business in federal procurement markets. The place of performance is listed as Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499.99 million and valid through November 2026. The parent contract enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established position as a critical supplier in the federal pharmaceutical supply chain, combined with its extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables, positions the company as a key distributor for military health facilities.
Quick answers
Who was awarded contract SPE2DB25FDM05?
SPE2DB25FDM05 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FDM05 worth?
The government has obligated $24,259 on SPE2DB25FDM05.
Is contract SPE2DB25FDM05 an order under another contract?
Yes. SPE2DB25FDM05 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM05 competed?
The extent of competition for SPE2DB25FDM05 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award